메뉴 건너뛰기




Volumn 55, Issue 2, 2007, Pages 97-105

Do high doses of quinolones decrease the emergence of antibacterial resistance? A systematic review of data from comparative clinical trials

Author keywords

Ciprofloxacin; Fleroxacin; Fluoroquinolones; Levofloxacin; Moxifloxacin

Indexed keywords

CIPROFLOXACIN; LEVOFLOXACIN; MOXIFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

EID: 34447251263     PISSN: 01634453     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jinf.2007.03.003     Document Type: Review
Times cited : (8)

References (57)
  • 1
    • 0032481410 scopus 로고    scopus 로고
    • Low dosage and long treatment duration of beta-lactam: risk factors for carriage of penicillin-resistant Streptococcus pneumoniae
    • Guillemot D., Carbon C., Balkau B., Geslin P., Lecoeur H., Vauzelle-Kervroedan F., et al. Low dosage and long treatment duration of beta-lactam: risk factors for carriage of penicillin-resistant Streptococcus pneumoniae. JAMA 279 5 (1998) 365-370
    • (1998) JAMA , vol.279 , Issue.5 , pp. 365-370
    • Guillemot, D.1    Carbon, C.2    Balkau, B.3    Geslin, P.4    Lecoeur, H.5    Vauzelle-Kervroedan, F.6
  • 2
    • 33646823492 scopus 로고    scopus 로고
    • Pharmacodynamics: relation to antimicrobial resistance
    • Rybak M.J. Pharmacodynamics: relation to antimicrobial resistance. Am J Med 119 6 Suppl. 1 (2006) S37-S44
    • (2006) Am J Med , vol.119 , Issue.6 SUPPL. 1
    • Rybak, M.J.1
  • 3
    • 2442549489 scopus 로고    scopus 로고
    • Relationship between fluoroquinolone area under the curve: minimum inhibitory concentration ratio and the probability of eradication of the infecting pathogen, in patients with nosocomial pneumonia
    • Drusano G.L., Preston S.L., Fowler C., Corrado M., Weisinger B., and Kahn J. Relationship between fluoroquinolone area under the curve: minimum inhibitory concentration ratio and the probability of eradication of the infecting pathogen, in patients with nosocomial pneumonia. J Infect Dis 189 9 (2004) 1590-1597
    • (2004) J Infect Dis , vol.189 , Issue.9 , pp. 1590-1597
    • Drusano, G.L.1    Preston, S.L.2    Fowler, C.3    Corrado, M.4    Weisinger, B.5    Kahn, J.6
  • 4
    • 0033628622 scopus 로고    scopus 로고
    • Pharmacodynamic modeling of risk factors for ciprofloxacin resistance in Pseudomonas aeruginosa
    • Hyatt J.M., and Schentag J.J. Pharmacodynamic modeling of risk factors for ciprofloxacin resistance in Pseudomonas aeruginosa. Infect Control Hosp Epidemiol 21 Suppl. 1 (2000) S9-S11
    • (2000) Infect Control Hosp Epidemiol , vol.21 , Issue.SUPPL. 1
    • Hyatt, J.M.1    Schentag, J.J.2
  • 5
    • 1642277881 scopus 로고    scopus 로고
    • Gatifloxacin 200 mg or 400 mg once daily is as effective as ciprofloxacin 500 mg twice daily for the treatment of patients with acute pyelonephritis or complicated urinary tract infections
    • Naber K.G., Bartnicki A., Bischoff W., Hanus M., Milutinovic S., van Belle F., et al. Gatifloxacin 200 mg or 400 mg once daily is as effective as ciprofloxacin 500 mg twice daily for the treatment of patients with acute pyelonephritis or complicated urinary tract infections. Int J Antimicrob Agents 23 Suppl. 1 (2004) S41-S53
    • (2004) Int J Antimicrob Agents , vol.23 , Issue.SUPPL. 1
    • Naber, K.G.1    Bartnicki, A.2    Bischoff, W.3    Hanus, M.4    Milutinovic, S.5    van Belle, F.6
  • 6
    • 1942534571 scopus 로고    scopus 로고
    • Efficacy of 750-mg, 5-day levofloxacin in the treatment of community-acquired pneumonia caused by atypical pathogens
    • Dunbar L.M., Khashab M.M., Kahn J.B., Zadeikis N., Xiang J.X., and Tennenberg A.M. Efficacy of 750-mg, 5-day levofloxacin in the treatment of community-acquired pneumonia caused by atypical pathogens. Curr Med Res Opin 20 4 (2004) 555-563
    • (2004) Curr Med Res Opin , vol.20 , Issue.4 , pp. 555-563
    • Dunbar, L.M.1    Khashab, M.M.2    Kahn, J.B.3    Zadeikis, N.4    Xiang, J.X.5    Tennenberg, A.M.6
  • 7
    • 0028909402 scopus 로고
    • Short-course ciprofloxacin treatment of acute uncomplicated urinary tract infection in women. The minimum effective dose. The Urinary Tract Infection Study Group [corrected]
    • Iravani A., Tice A.D., McCarty J., Sikes D.H., Nolen T., Gallis H.A., et al. Short-course ciprofloxacin treatment of acute uncomplicated urinary tract infection in women. The minimum effective dose. The Urinary Tract Infection Study Group [corrected]. Arch Intern Med 155 5 (1995) 485-494
    • (1995) Arch Intern Med , vol.155 , Issue.5 , pp. 485-494
    • Iravani, A.1    Tice, A.D.2    McCarty, J.3    Sikes, D.H.4    Nolen, T.5    Gallis, H.A.6
  • 8
    • 0027418044 scopus 로고
    • Randomized double-blind trial of high- and low-dose fleroxacin versus norfloxacin for complicated urinary tract infection
    • Pittman W., Moon J.O., Hamrick Jr. L.C., Cox C.E., Clark J., Childs S., et al. Randomized double-blind trial of high- and low-dose fleroxacin versus norfloxacin for complicated urinary tract infection. Am J Med 94 3A (1993) 101S-104S
    • (1993) Am J Med , vol.94 , Issue.3 A
    • Pittman, W.1    Moon, J.O.2    Hamrick Jr., L.C.3    Cox, C.E.4    Clark, J.5    Childs, S.6
  • 9
    • 0033631281 scopus 로고    scopus 로고
    • Potential role of pharmacokinetics, pharmacodynamics, and computerized databases in controlling bacterial resistance
    • Hyatt J.M., and Schentag J.J. Potential role of pharmacokinetics, pharmacodynamics, and computerized databases in controlling bacterial resistance. Infect Control Hosp Epidemiol 21 Suppl. 1 (2000) S18-S21
    • (2000) Infect Control Hosp Epidemiol , vol.21 , Issue.SUPPL. 1
    • Hyatt, J.M.1    Schentag, J.J.2
  • 10
    • 0031940776 scopus 로고    scopus 로고
    • Pharmacodynamic evaluation of factors associated with the development of bacterial resistance in acutely ill patients during therapy
    • Thomas J.K., Forrest A., Bhavnani S.M., Hyatt J.M., Cheng A., Ballow C.H., et al. Pharmacodynamic evaluation of factors associated with the development of bacterial resistance in acutely ill patients during therapy. Antimicrob Agents Chemother 42 3 (1998) 521-527
    • (1998) Antimicrob Agents Chemother , vol.42 , Issue.3 , pp. 521-527
    • Thomas, J.K.1    Forrest, A.2    Bhavnani, S.M.3    Hyatt, J.M.4    Cheng, A.5    Ballow, C.H.6
  • 11
    • 0030724627 scopus 로고    scopus 로고
    • Comparison of two regimens for ciprofloxacin treatment of enteric infections
    • Agalar C., Usubutun S., Tutuncu E., and Turkyilmaz R. Comparison of two regimens for ciprofloxacin treatment of enteric infections. Eur J Clin Microbiol Infect Dis 16 11 (1997) 803-806
    • (1997) Eur J Clin Microbiol Infect Dis , vol.16 , Issue.11 , pp. 803-806
    • Agalar, C.1    Usubutun, S.2    Tutuncu, E.3    Turkyilmaz, R.4
  • 12
    • 0022851507 scopus 로고
    • Clinical efficacy of ofloxacin in the treatment of otorhinolaryngological infections
    • Baba S. Clinical efficacy of ofloxacin in the treatment of otorhinolaryngological infections. Infection 14 Suppl. 4 (1986) S327-S331
    • (1986) Infection , vol.14 , Issue.SUPPL. 4
    • Baba, S.1
  • 14
    • 0024419440 scopus 로고
    • Dose-ranging study of fleroxacin for treatment of uncomplicated Chlamydia trachomatis genital infections
    • Bowie W.R., Willetts V., and Megran D.W. Dose-ranging study of fleroxacin for treatment of uncomplicated Chlamydia trachomatis genital infections. Antimicrob Agents Chemother 33 10 (1989) 1774-1777
    • (1989) Antimicrob Agents Chemother , vol.33 , Issue.10 , pp. 1774-1777
    • Bowie, W.R.1    Willetts, V.2    Megran, D.W.3
  • 15
    • 0027512978 scopus 로고
    • Treatment of acute bacterial diarrhea: a multicenter international trial comparing placebo with fleroxacin given as a single dose or once daily for 3 days
    • Butler T., Lolekha S., Rasidi C., Kadio A., del Rosal P.L., Iskandar H., et al. Treatment of acute bacterial diarrhea: a multicenter international trial comparing placebo with fleroxacin given as a single dose or once daily for 3 days. Am J Med 94 3A (1993) 187S-194S
    • (1993) Am J Med , vol.94 , Issue.3 A
    • Butler, T.1    Lolekha, S.2    Rasidi, C.3    Kadio, A.4    del Rosal, P.L.5    Iskandar, H.6
  • 16
    • 0032973962 scopus 로고    scopus 로고
    • Clinical effectiveness of levofloxacin in patients with acute purulent exacerbations of chronic bronchitis: the relationship with in-vitro activity
    • Davies B.I., and Maesen F.P. Clinical effectiveness of levofloxacin in patients with acute purulent exacerbations of chronic bronchitis: the relationship with in-vitro activity. J Antimicrob Chemother 43 Suppl. C (1999) 83-90
    • (1999) J Antimicrob Chemother , vol.43 , Issue.SUPPL. C , pp. 83-90
    • Davies, B.I.1    Maesen, F.P.2
  • 17
    • 0036239477 scopus 로고    scopus 로고
    • Pharmacokinetic parameters of ciprofloxacin (500 mg/5 mL). Oral suspension in critically ill patients with severe bacterial pneumonia: a comparison of two dosages
    • Debon R., Breilh D., Boselli E., Saux M.C., Duflo F., Chassard D., et al. Pharmacokinetic parameters of ciprofloxacin (500 mg/5 mL). Oral suspension in critically ill patients with severe bacterial pneumonia: a comparison of two dosages. J Chemother 14 2 (2002) 175-180
    • (2002) J Chemother , vol.14 , Issue.2 , pp. 175-180
    • Debon, R.1    Breilh, D.2    Boselli, E.3    Saux, M.C.4    Duflo, F.5    Chassard, D.6
  • 18
    • 0141676184 scopus 로고    scopus 로고
    • High-dose, short-course levofloxacin for community-acquired pneumonia: a new treatment paradigm
    • Dunbar L.M., Wunderink R.G., Habib M.P., Smith L.G., Tennenberg A.M., Khashab M.M., et al. High-dose, short-course levofloxacin for community-acquired pneumonia: a new treatment paradigm. Clin Infect Dis 37 6 (2003) 752-760
    • (2003) Clin Infect Dis , vol.37 , Issue.6 , pp. 752-760
    • Dunbar, L.M.1    Wunderink, R.G.2    Habib, M.P.3    Smith, L.G.4    Tennenberg, A.M.5    Khashab, M.M.6
  • 19
    • 0023630774 scopus 로고
    • Use of norfloxacin in the treatment of acute diarrheal disease
    • Dupont H.L., Corrado M.L., and Sabbaj J. Use of norfloxacin in the treatment of acute diarrheal disease. Am J Med 82 6B (1987) 79-83
    • (1987) Am J Med , vol.82 , Issue.6 B , pp. 79-83
    • Dupont, H.L.1    Corrado, M.L.2    Sabbaj, J.3
  • 20
    • 5444275363 scopus 로고    scopus 로고
    • Clinical implications of 750 mg, 5-day levofloxacin for the treatment of community-acquired pneumonia
    • File Jr. T.M., Milkovich G., Tennenberg A.M., Xiang J.X., Khashab M.M., and Zadeikis N. Clinical implications of 750 mg, 5-day levofloxacin for the treatment of community-acquired pneumonia. Curr Med Res Opin 20 9 (2004) 1473-1481
    • (2004) Curr Med Res Opin , vol.20 , Issue.9 , pp. 1473-1481
    • File Jr., T.M.1    Milkovich, G.2    Tennenberg, A.M.3    Xiang, J.X.4    Khashab, M.M.5    Zadeikis, N.6
  • 21
    • 0028105983 scopus 로고
    • Study of the efficacy and safety of ciprofloxacin in the treatment of chronic otitis
    • Fombeur J.P., Barrault S., Koubbi G., Laurier J.N., Ebbo D., Lecomte F., et al. Study of the efficacy and safety of ciprofloxacin in the treatment of chronic otitis. Chemotherapy 40 Suppl. 1 (1994) 29-34
    • (1994) Chemotherapy , vol.40 , Issue.SUPPL. 1 , pp. 29-34
    • Fombeur, J.P.1    Barrault, S.2    Koubbi, G.3    Laurier, J.N.4    Ebbo, D.5    Lecomte, F.6
  • 23
    • 0027197110 scopus 로고
    • Development of a population pharmacokinetic model and optimal sampling strategies for intravenous ciprofloxacin
    • Forrest A., Ballow C.H., Nix D.E., Birmingham M.C., and Schentag J.J. Development of a population pharmacokinetic model and optimal sampling strategies for intravenous ciprofloxacin. Antimicrob Agents Chemother 37 5 (1993) 1065-1072
    • (1993) Antimicrob Agents Chemother , vol.37 , Issue.5 , pp. 1065-1072
    • Forrest, A.1    Ballow, C.H.2    Nix, D.E.3    Birmingham, M.C.4    Schentag, J.J.5
  • 24
    • 0023106978 scopus 로고
    • Single-dose ciprofloxacin at 100 versus 250 mg for treatment of uncomplicated urinary tract infections in women
    • Garlando F., Rietiker S., Tauber M.G., Flepp M., Meier B., and Luthy R. Single-dose ciprofloxacin at 100 versus 250 mg for treatment of uncomplicated urinary tract infections in women. Antimicrob Agents Chemother 31 2 (1987) 354-356
    • (1987) Antimicrob Agents Chemother , vol.31 , Issue.2 , pp. 354-356
    • Garlando, F.1    Rietiker, S.2    Tauber, M.G.3    Flepp, M.4    Meier, B.5    Luthy, R.6
  • 25
    • 0029091757 scopus 로고
    • Comparative assessment of the pharmacokinetics and pharmacodynamics of ciprofloxacin after single i.v. doses of 200 and 400 mg
    • Garraffo R., and Drugeon H.B. Comparative assessment of the pharmacokinetics and pharmacodynamics of ciprofloxacin after single i.v. doses of 200 and 400 mg. Drugs 49 Suppl. 2 (1995) 317-320
    • (1995) Drugs , vol.49 , Issue.SUPPL. 2 , pp. 317-320
    • Garraffo, R.1    Drugeon, H.B.2
  • 26
    • 0032973850 scopus 로고    scopus 로고
    • Comparative study of single-dose and three-day therapy for acute uncomplicated cystitis
    • Goto T., Kitagawa T., Kawahara M., Hayami H., and Ohi Y. Comparative study of single-dose and three-day therapy for acute uncomplicated cystitis. Hinyokika Kiyo 45 2 (1999) 85-89
    • (1999) Hinyokika Kiyo , vol.45 , Issue.2 , pp. 85-89
    • Goto, T.1    Kitagawa, T.2    Kawahara, M.3    Hayami, H.4    Ohi, Y.5
  • 27
    • 0023518275 scopus 로고
    • Clinical efficacy of ofloxacin in lower respiratory tract infections. A multicentre study
    • Grassi C., Gialdroni G.G., and Mangiarotti P. Clinical efficacy of ofloxacin in lower respiratory tract infections. A multicentre study. Drugs 34 Suppl. 1 (1987) 80-82
    • (1987) Drugs , vol.34 , Issue.SUPPL. 1 , pp. 80-82
    • Grassi, C.1    Gialdroni, G.G.2    Mangiarotti, P.3
  • 28
    • 0022858732 scopus 로고
    • A multicenter study on clinical efficacy of ofloxacin in respiratory and urinary tract infections
    • Grassi G.G. A multicenter study on clinical efficacy of ofloxacin in respiratory and urinary tract infections. Infection 14 Suppl. 4 (1986) S300-S302
    • (1986) Infection , vol.14 , Issue.SUPPL. 4
    • Grassi, G.G.1
  • 29
    • 0034933394 scopus 로고    scopus 로고
    • The efficacy and safety of two oral moxifloxacin regimens compared to oral clarithromycin in the treatment of community-acquired pneumonia
    • Hoeffken G., Meyer H.P., Winter J., and Verhoef L. The efficacy and safety of two oral moxifloxacin regimens compared to oral clarithromycin in the treatment of community-acquired pneumonia. Respir Med 95 7 (2001) 553-564
    • (2001) Respir Med , vol.95 , Issue.7 , pp. 553-564
    • Hoeffken, G.1    Meyer, H.P.2    Winter, J.3    Verhoef, L.4
  • 30
    • 0027518578 scopus 로고
    • Single dose therapy of uncomplicated urinary tract infections in women. Remission rates with ciprofloxacin in two prospective randomized comparative studies]
    • Hoyme U.B., Alimi M., Keuter U., Krasemann C., Krolla H., Moayer M., et al. Single dose therapy of uncomplicated urinary tract infections in women. Remission rates with ciprofloxacin in two prospective randomized comparative studies]. Fortschr Med 111 3 (1993) 45-48
    • (1993) Fortschr Med , vol.111 , Issue.3 , pp. 45-48
    • Hoyme, U.B.1    Alimi, M.2    Keuter, U.3    Krasemann, C.4    Krolla, H.5    Moayer, M.6
  • 32
    • 0027418043 scopus 로고
    • Multicenter study of single-dose and multiple-dose fleroxacin versus ciprofloxacin in the treatment of uncomplicated urinary tract infections
    • Iravani A. Multicenter study of single-dose and multiple-dose fleroxacin versus ciprofloxacin in the treatment of uncomplicated urinary tract infections. Am J Med 94 3A (1993) 89S-96S
    • (1993) Am J Med , vol.94 , Issue.3 A
    • Iravani, A.1
  • 34
    • 0026319883 scopus 로고
    • Value of single-dose ciprofloxacin in the treatment of acute uncomplicated urinary tract infection in women
    • Karachalios G.N., Georgiopoulos A.N., Nasopoulou-Papadimitriou D.D., and Adracta D.J. Value of single-dose ciprofloxacin in the treatment of acute uncomplicated urinary tract infection in women. Drugs Exp Clin Res 17 10-11 (1991) 521-524
    • (1991) Drugs Exp Clin Res , vol.17 , Issue.10-11 , pp. 521-524
    • Karachalios, G.N.1    Georgiopoulos, A.N.2    Nasopoulou-Papadimitriou, D.D.3    Adracta, D.J.4
  • 35
    • 0024368510 scopus 로고
    • Efficacy and safety of higher-dose intravenous ciprofloxacin in severe hospital-acquired infections
    • Kljucar S., Heimesaat M., von Pritzbuer E., Timm J., Scholl H., and Beermann D. Efficacy and safety of higher-dose intravenous ciprofloxacin in severe hospital-acquired infections. Am J Med 87 5A (1989) 52S-56S
    • (1989) Am J Med , vol.87 , Issue.5 A
    • Kljucar, S.1    Heimesaat, M.2    von Pritzbuer, E.3    Timm, J.4    Scholl, H.5    Beermann, D.6
  • 36
    • 0032966498 scopus 로고    scopus 로고
    • Ciprofloxacin once versus twice daily in the treatment of complicated urinary tract infections. German Ciprofloxacin UTI Study Group
    • Krcmery S., and Naber K.G. Ciprofloxacin once versus twice daily in the treatment of complicated urinary tract infections. German Ciprofloxacin UTI Study Group. Int J Antimicrob Agents 11 2 (1999) 133-138
    • (1999) Int J Antimicrob Agents , vol.11 , Issue.2 , pp. 133-138
    • Krcmery, S.1    Naber, K.G.2
  • 37
    • 0023025449 scopus 로고
    • Clinical, microbiological and pharmacokinetic studies on ofloxacin in acute purulent exacerbations of chronic respiratory disease
    • Maesen F.P., Davies B.I., Baur C., and Sumajow C.A. Clinical, microbiological and pharmacokinetic studies on ofloxacin in acute purulent exacerbations of chronic respiratory disease. J Antimicrob Chemother 18 5 (1986) 629-634
    • (1986) J Antimicrob Chemother , vol.18 , Issue.5 , pp. 629-634
    • Maesen, F.P.1    Davies, B.I.2    Baur, C.3    Sumajow, C.A.4
  • 38
    • 0036776081 scopus 로고    scopus 로고
    • Lower dose of ciprofloxacin is adequate for the treatment of Neisseria gonorrhoeae in KwaZulu Natal, South Africa
    • Moodley P., Pillay C., Nzimande G., Coovadia Y.M., and Sturm A.W. Lower dose of ciprofloxacin is adequate for the treatment of Neisseria gonorrhoeae in KwaZulu Natal, South Africa. Int J Antimicrob Agents 20 4 (2002) 248-252
    • (2002) Int J Antimicrob Agents , vol.20 , Issue.4 , pp. 248-252
    • Moodley, P.1    Pillay, C.2    Nzimande, G.3    Coovadia, Y.M.4    Sturm, A.W.5
  • 39
    • 0023611042 scopus 로고
    • Oral ciprofloxacin in the treatment of serious soft tissue and bone infections. Efficacy, safety, and pharmacokinetics
    • Nix D.E., Cumbo T.J., Kuritzky P., DeVito J.M., and Schentag J.J. Oral ciprofloxacin in the treatment of serious soft tissue and bone infections. Efficacy, safety, and pharmacokinetics. Am J Med 82 4A (1987) 146-153
    • (1987) Am J Med , vol.82 , Issue.4 A , pp. 146-153
    • Nix, D.E.1    Cumbo, T.J.2    Kuritzky, P.3    DeVito, J.M.4    Schentag, J.J.5
  • 40
    • 0024308248 scopus 로고
    • Therapy of lower extremity infections with ciprofloxacin in patients with diabetes mellitus, peripheral vascular disease, or both
    • Peterson L.R., Lissack L.M., Canter K., Fasching C.E., Clabots C., and Gerding D.N. Therapy of lower extremity infections with ciprofloxacin in patients with diabetes mellitus, peripheral vascular disease, or both. Am J Med 86 6 Pt 2 (1989) 801-808
    • (1989) Am J Med , vol.86 , Issue.6 PART 2 , pp. 801-808
    • Peterson, L.R.1    Lissack, L.M.2    Canter, K.3    Fasching, C.E.4    Clabots, C.5    Gerding, D.N.6
  • 41
    • 0031944261 scopus 로고    scopus 로고
    • Efficacy and safety of norfloxacin 800 mg once-daily versus norfloxacin 400 mg twice-daily in the treatment of uncomplicated urinary tract infections in women: a double-blind, randomized clinical trial
    • Pimentel F.L., Dolgner A., Guimaraes J., Quintas M., and Mario-Reis J. Efficacy and safety of norfloxacin 800 mg once-daily versus norfloxacin 400 mg twice-daily in the treatment of uncomplicated urinary tract infections in women: a double-blind, randomized clinical trial. J Chemother 10 2 (1998) 122-127
    • (1998) J Chemother , vol.10 , Issue.2 , pp. 122-127
    • Pimentel, F.L.1    Dolgner, A.2    Guimaraes, J.3    Quintas, M.4    Mario-Reis, J.5
  • 42
    • 29944439506 scopus 로고    scopus 로고
    • A trial of high-dose, short-course levofloxacin for the treatment of acute bacterial sinusitis
    • Poole M., Anon, Paglia M., Xiang J., Khashab M., and Kahn J. A trial of high-dose, short-course levofloxacin for the treatment of acute bacterial sinusitis. Otolaryngol Head Neck Surg 134 1 (2006) 10-17
    • (2006) Otolaryngol Head Neck Surg , vol.134 , Issue.1 , pp. 10-17
    • Poole, M.1    Paglia, M.2    Xiang, J.3    Khashab, M.4    Kahn, J.5
  • 43
    • 0031905679 scopus 로고    scopus 로고
    • Efficacy and tolerability of twice-daily ciprofloxacin 750 mg in the treatment of patients with acute exacerbations of chronic bronchitis and pneumonia
    • Pryka R., Kowalsky S., and Haverstock D. Efficacy and tolerability of twice-daily ciprofloxacin 750 mg in the treatment of patients with acute exacerbations of chronic bronchitis and pneumonia. Clin Ther 20 1 (1998) 141-155
    • (1998) Clin Ther , vol.20 , Issue.1 , pp. 141-155
    • Pryka, R.1    Kowalsky, S.2    Haverstock, D.3
  • 44
    • 0028183191 scopus 로고
    • [The efficacy and tolerance of Bay-o-9867 (ciprofloxacin. in the treatment of infections of the urinary tract and of the lower respiratory tract]
    • Quartieri F., Bolognesi S., and Sconosciuto F. [The efficacy and tolerance of Bay-o-9867 (ciprofloxacin. in the treatment of infections of the urinary tract and of the lower respiratory tract]. Recenti Prog Med 85 2 (1994) 96-100
    • (1994) Recenti Prog Med , vol.85 , Issue.2 , pp. 96-100
    • Quartieri, F.1    Bolognesi, S.2    Sconosciuto, F.3
  • 45
    • 9044223656 scopus 로고    scopus 로고
    • Ofloxacin once daily versus twice daily in community-acquired pneumonia and acute exacerbation of chronic bronchitis. A randomized multicenter study
    • Rayman J., Krchnavy M., Balciar P., Duchon J., Fortunik J., Faith L., et al. Ofloxacin once daily versus twice daily in community-acquired pneumonia and acute exacerbation of chronic bronchitis. A randomized multicenter study. Chemotherapy 42 3 (1996) 227-230
    • (1996) Chemotherapy , vol.42 , Issue.3 , pp. 227-230
    • Rayman, J.1    Krchnavy, M.2    Balciar, P.3    Duchon, J.4    Fortunik, J.5    Faith, L.6
  • 46
    • 0024788087 scopus 로고
    • Single-dose ciprofloxacin in the treatment of uncomplicated urinary tract infection in women
    • Raz R., Rottensterich E., Hefter H., Kennes Y., and Potasman I. Single-dose ciprofloxacin in the treatment of uncomplicated urinary tract infection in women. Eur J Clin Microbiol Infect Dis 8 12 (1989) 1040-1042
    • (1989) Eur J Clin Microbiol Infect Dis , vol.8 , Issue.12 , pp. 1040-1042
    • Raz, R.1    Rottensterich, E.2    Hefter, H.3    Kennes, Y.4    Potasman, I.5
  • 47
    • 0023475835 scopus 로고
    • Ofloxacin in respiratory tract infection. A review of the results of clinical trials in Japan
    • Saito A., Katsu M., Saito A., and Soejima R. Ofloxacin in respiratory tract infection. A review of the results of clinical trials in Japan. Drugs 34 Suppl. 1 (1987) 83-89
    • (1987) Drugs , vol.34 , Issue.SUPPL. 1 , pp. 83-89
    • Saito, A.1    Katsu, M.2    Saito, A.3    Soejima, R.4
  • 49
    • 0023609577 scopus 로고
    • Randomized study of two dosage regimens of ciprofloxacin for treating chronic bronchopulmonary infection in patients with cystic fibrosis
    • Shalit I., Stutman H.R., Marks M.I., Chartrand S.A., and Hilman B.C. Randomized study of two dosage regimens of ciprofloxacin for treating chronic bronchopulmonary infection in patients with cystic fibrosis. Am J Med 82 4A (1987) 189-195
    • (1987) Am J Med , vol.82 , Issue.4 A , pp. 189-195
    • Shalit, I.1    Stutman, H.R.2    Marks, M.I.3    Chartrand, S.A.4    Hilman, B.C.5
  • 50
    • 0029116216 scopus 로고
    • Oral levofloxacin 600 mg and 300 mg daily doses in difficult-to-treat respiratory infections
    • Shishido H., Furukawa K., Nagai H., Kawakami K., and Kono H. Oral levofloxacin 600 mg and 300 mg daily doses in difficult-to-treat respiratory infections. Drugs 49 Suppl. 2 (1995) 433-435
    • (1995) Drugs , vol.49 , Issue.SUPPL. 2 , pp. 433-435
    • Shishido, H.1    Furukawa, K.2    Nagai, H.3    Kawakami, K.4    Kono, H.5
  • 51
    • 0023748853 scopus 로고
    • Therapy of acute and chronic gram-negative osteomyelitis with ciprofloxacin. Report from a Swedish Study Group
    • Swedish Study Group. Therapy of acute and chronic gram-negative osteomyelitis with ciprofloxacin. Report from a Swedish Study Group. J Antimicrob Chemother 22 2 (1988) 221-228
    • (1988) J Antimicrob Chemother , vol.22 , Issue.2 , pp. 221-228
    • Swedish Study Group1
  • 52
    • 0033802398 scopus 로고    scopus 로고
    • Oral ciprofloxacin after a short course of intravenous ciprofloxacin in the treatment of spontaneous bacterial peritonitis: results of a multicenter, randomized study
    • Terg R., Cobas S., Fassio E., Landeira G., Rios B., Vasen W., et al. Oral ciprofloxacin after a short course of intravenous ciprofloxacin in the treatment of spontaneous bacterial peritonitis: results of a multicenter, randomized study. J Hepatol 33 4 (2000) 564-569
    • (2000) J Hepatol , vol.33 , Issue.4 , pp. 564-569
    • Terg, R.1    Cobas, S.2    Fassio, E.3    Landeira, G.4    Rios, B.5    Vasen, W.6
  • 53
    • 0032171550 scopus 로고    scopus 로고
    • Effects of oral ciprofloxacin on aerobic gram-negative fecal flora in patients with cirrhosis: results of short- and long-term administration, with daily and weekly dosages
    • Terg R., Llano K., Cobas S.M., Brotto C., Barrios A., Levi D., et al. Effects of oral ciprofloxacin on aerobic gram-negative fecal flora in patients with cirrhosis: results of short- and long-term administration, with daily and weekly dosages. J Hepatol 29 3 (1998) 437-442
    • (1998) J Hepatol , vol.29 , Issue.3 , pp. 437-442
    • Terg, R.1    Llano, K.2    Cobas, S.M.3    Brotto, C.4    Barrios, A.5    Levi, D.6
  • 54
    • 0027068199 scopus 로고
    • Randomized prospective study comparing two dosage regimens of ciprofloxacin for the treatment of typhoid fever
    • Uwaydah A.K., al Soub H., and Matar I. Randomized prospective study comparing two dosage regimens of ciprofloxacin for the treatment of typhoid fever. J Antimicrob Chemother 30 5 (1992) 707-711
    • (1992) J Antimicrob Chemother , vol.30 , Issue.5 , pp. 707-711
    • Uwaydah, A.K.1    al Soub, H.2    Matar, I.3
  • 55
    • 0025008720 scopus 로고
    • Double-blind, dose-range-finding study of fleroxacin (RO 23-6240; AM-833. for treatment of complicated urinary tract infections
    • Wolfhagen M.J., Hoepelman A.I., and Verhoef J. Double-blind, dose-range-finding study of fleroxacin (RO 23-6240; AM-833. for treatment of complicated urinary tract infections. Antimicrob Agents Chemother 34 3 (1990) 409-412
    • (1990) Antimicrob Agents Chemother , vol.34 , Issue.3 , pp. 409-412
    • Wolfhagen, M.J.1    Hoepelman, A.I.2    Verhoef, J.3
  • 56
    • 0024306223 scopus 로고
    • Ciprofloxacin intravenous dose variance
    • Lode H., Hoffken G., Borner K., and Koeppe P. Ciprofloxacin intravenous dose variance. Am J Med 87 5A (1989) 40S-45S
    • (1989) Am J Med , vol.87 , Issue.5 A
    • Lode, H.1    Hoffken, G.2    Borner, K.3    Koeppe, P.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.